• Oncorus to Build GMP Viral Immunotherapy Mfg. Facility contractpharma
    January 05, 2021
    Oncorus, Inc., a clinical stage biopharmaceutical company developing next-gen viral immunotherapies for cancer, has signed a 15-year lease to build a state-of-the-art, 88,000 sq.-ft. GMP viral immunotherapy clinical manufacturing facility in Andover ...
PharmaSources Customer Service